OPR - Delayed Quote • USD ENTX May 2024 5.000 call (ENTX240517C00005000) Follow 0.0500 0.0000 (0.00%) At close: April 25 at 2:05 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for ENTX240517C00005000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: ENTX Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? Here's Why You Should Invest in Entera Bio (ENTX) Stock Now Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months OPKO Health (OPK) And Entera Bio Announce Data for GLP-2 12 Best Biotech Penny Stocks to Invest In We Think Entera Bio (NASDAQ:ENTX) Can Afford To Drive Business Growth Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
